approval
saveBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 7
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalMar 30, 2026 · 235d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalNov 12, 2025 · 373d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalAug 15, 2025 · 462d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalOct 3, 2023 · 1144d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalJun 16, 2023 · 1253d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalJun 9, 2022 · 1625d ago
- approvalBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalSep 17, 2021 · 1890d ago
comments(0)
5-min edit window · permanent after that